CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(04): E561-E567
DOI: 10.1055/a-0867-9450
Innovation forum
Owner and Copyright © Georg Thieme Verlag KG 2019

Potential of temperature-response collagen-genipin sols as a novel submucosal injection material for endoscopic resection

Yusaku Takatori
1   Department of Gastroenterology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan
2   Department of Gastroenterology, National Hospital Organization Saitama Hospital, Saitama, Japan
3   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan
,
Toshio Uraoka
4   Department of Gastroenterology and Hepatology, Gunma University School of Medicine, Gunma, Japan
,
Takefumi Narita
5   Biotechnology Group, Tokyo Metropolitan Industrial Technology Research Institute, Tokyo, Japan
,
Shunji Yunoki
5   Biotechnology Group, Tokyo Metropolitan Industrial Technology Research Institute, Tokyo, Japan
,
Naohisa Yahagi
3   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan
› Author Affiliations
Further Information

Corresponding author

Toshio Uraoka, MD, PhD
Department of Gastroenterology and Hepatology
Gunma University School of Medicine
3-39-22, Showa-machi, Maebashi-shi
Gunma, 371-8511
Japan   
Fax: +81-27-220-7798   

Publication History

submitted 01 September 2018

accepted after revision 14 February 2019

Publication Date:
04 April 2019 (online)

 

Abstract

Background and study aims We developed a novel submucosal (SM) injection material that contained pepsin-solubilized collagen (PSC), genipin (Ge) and phosphate buffer (PB). The aim of this study was to validate safety and usability of it for endoscopic resection (ER).

Materials and methods In preliminary studies, 1) appropriate warming time and concentration of Ge, and concentration of NaCl in PB, 2) storage modulus of PSC, Ge, and PB mixture (PSC/Ge), and PSC as a mechanical property, 3) histological finding after injection, and histological toxicity of PSC/Ge was evaluated. We injected PSC/Ge, PSC, sodium hyaluronate (SH), dextrose (DW), and normal saline (NS) into SM of resected porcine stomach. We compared mean height of mucosal elevation after immediate injection (MH) and mean retaining rate at 60 minutes (MR) as ex vivo study.

Results Optimal condition of PSC/Ge was Ge 5.5 mMol with 24 hours worming time and NaCl 280 mMol. PSC/Ge had better mechanical property than PSC. It was efficiently integrated and confined to the SM with acceptable toxicity. MH of PSC/Ge (5.1 ± 0.74 mm) and PSC (4.8 ± 0.84 mm) were significantly higher than NS (3.2 ± 0.84 mm). MR of PSC/Ge (100 ± 0.0%) was significantly higher than NS (61.7 ± 11.2%), DW (58.3 ± 11.8%) and SH (61.8 ± 8.6%).

Conclusion PSC/Ge and PSC has potential to be safe and usable for ER. PSC/Ge was better than PSC because of better mechanical property than PSC.


#

Introduction

Endoscopic mucosal resection and endoscopic submucosal dissection are becoming widespread and standard techniques as minimally invasive therapies for early-stage gastrointestinal tumors because of progress in performance of endoscopy and devices [1] [2].

Normal saline (NS) is commonly used as submucosal injection material in clinical practice because of its low cost and lack of toxicity to human tissue. However, use of NS may necessitate multiple injections during the procedure because it is quickly absorbed by surrounding tissue and unable to maintain mucosal lifting for a long period [3], which may ultimately lead to prolonged operation times and increased risk of perforation. Therefore, some alternative agents have been proposed for use in submucosal injection to shorten procedure time and provide safer procedure outcomes.

In clinical practice, dextrose (DW) and sodium hyaluronate (SH) are also used as submucosal injection material for endoscopic treatment. However, DW is quickly absorbed by surrounding tissue and cannot maintain mucosal lifting for long periods of time, similar to NS [4]. Although SH exhibits good viscosity (better than that of NS) and low toxicity, its use in clinical practice is limited because of its high cost. Other materials have been used for submucosal injections, but only a few materials are utilized clinically [3] [5] [6] [7] [8] [9] [10].

In a previous study, use of pepsin-digested collagen was proposed because its mechanical properties are increased by genipin as a result of genipin-induced crosslinking, and collagen itself presents temperature responsiveness [11]. Collagen maintains fluidity at room temperature, while increasing temperatures cause gelation and eventually result in solid gels [12]. In addition, collagen is able to fix the properties of a gel depending on the NaCl concentration in phosphate buffer [13]. Therefore, we conducted this study to evaluate the possibility of using collagen sol and genipin as a submucosal injection material for endoscopic therapy.


#

Material and methods

This study was conducted in the laboratory of the National Hospital Organization Tokyo Medical Center and Tokyo Metropolitan Industrial Technology Research Institute. All animal tests were approved by the animal ethics committee of both institutions.

Materials

Pepsin-solubilized collagen (PSC) at pH 3 was diluted in HCl (1 % solution of mainly type I collagen from porcine skin, Nipponham, Japan). Acid-solubilized collagen at pH 3 was diluted in HCl (0.3 % solution of mainly type I collagen from porcine tendon, Nitta Gelatin, Japan). Genipin (Ge; Wako Pure Chemical Industries, Japan), phosphate buffered saline (PBS) tablets (Sigma-Aldrich, MO), disodium hydrogen phosphate (Na2HPO4; Wako Pure Chemical Industries, Japan), sodium dihydrogen phosphate (NaH2PO4; Wako Pure Chemical Industries, Japan), NIH/3T3 fibroblast cells (RIKEN RCB2767), Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich, MO), calf serum (CS; MP Biomedicals, Germany), antibiotic-antimycotic (Gibco, NY), Cell Counting Kit-8 (CCK-8; Dojindo Laboratories, Japan), 0.4 % SH (MucoUp, Boston Scientific Japan, Japan), 5 % DW and NS were purchased and used without further purification.


#

Adequate condition settings for collagen sol for an endoscopic procedure

As shown in the Introduction, the condition setting factors for collagen sol were the concentration of NaCl in PBS, warming time of genipin, and concentration of genipin.


#

Concentration of NaCl

To determine the NaCl concentration of PBS, we prepared PSC sol without genipin; 0.5 % neutral PSC sol was prepared by mixing three components: acidic PSC solution, deionized water, and neutral buffers. The components were prepared as follows: 1 % acidic PSC solution was concentrated to 2 % in a rotary evaporator at 29 °C and stored in aliquots (2 g) in biological tubes at 4 °C. Phosphate buffers (pH 7) were designated PB[X-Y], where X is the total concentration of Na2HPO4 /NaH2PO4, and Y is the NaCl concentration. The 2 % acidic PSC solution (2 g), deionized water (2 mL), and PB[100-Y] (Y: 0 – 840) (4 mL) were mixed vigorously, producing 0.5 % neutral PSC sol in PB[50-Y] (Y: 0 – 420) (designated PSC sol).

The PSC sol gelatins that responded to temperature were evaluated using dynamic viscoelastic tests with a rheometer. During oscillation, the temperature was maintained at 23 °C for 1 minute, then increased to 37 °C over 30 seconds to trigger gelation, and subsequently maintained at 37 °C to promote gelation. Changes in the storage (G′) and loss (G′′) moduli were registered throughout the test. The gel point was determined as the point at which G′ and G′′ intersected in their time-course changes. The gelation time at 37 °C (Tg37) was defined as the time to reach the gel point after the set temperature reached 37 °C Tg37 indicates the gelation rate of the collagen sol that responds to body temperature. We also measured the gelation time of the collagen sols at 30 °C (Tg30) in a manner similar to Tg37.

To determine the NaCl concentration and obtain inflection points for collagen fibril formation rates, Tg37 for various NaCl concentrations was plotted against Tg30. Finally, we determined the appropriate NaCl concentration resulting in rapid gelation at 37 °C and adequate fluidity at 30 °C


#

Warming time and concentration of genipin

PSC/Ge sol was prepared in a manner similar to preparation of PSC sol, except that deionized water was substituted with Ge solution. Ge solution was dissolved in PB[100 – 0] at a concentration of 22 mM and then warmed in a water bath at 37 °C for 12 hours, 24 hours, or 48 hours (designated Ge-12, Ge-24, and Ge-48).

A portion of the Ge solution was diluted from 22 mM to 11 mM and 5.5 mM with PB[100 – 0]. A Ge solution in PB[100-Y] without warming (designated Ge-0) was also prepared and similarly diluted. The 2 % acidic PSC solution (2 g), each of the Ge solutions at 5.5 – 22 mM in PB[100 – 0] (2 mL), and PB[50 – 560] (4 mL) were mixed vigorously, and 0.5 % neutral PSC/Ge sols in PB[50 – 280] containing 1.4 – 5.5 mM Ge-0, Ge-12, Ge-24, or Ge-48 were produced (designated PSC/Ge or PSC/Ge-x sols, where Ge indicates unspecified Ge-x).

PSC/Ge sol gelation was evaluated using dynamic viscoelastic tests with a rheometer, in a manner similar to the study of concentration of NaCL. First, we produced gelation curves for the PSC/Ge sols in relation to the warming time. We fixed the concentration of Ge at 5.5 mM. The sharpness of the curves was quantified by Tg37, which was plotted against the Ge concentration for each Ge sample. Second, the Tg37 for all conditions of the PSC/Ge sol was plotted against Tg30, and we finally determined the warming time and concentration of genipin needed to accelerate the gelation of PSC within approximately 1 minute.


#

Rheological evaluations of materials

To evaluate gelation speed and physical strength response to temperature, we evaluated the viscosity of submucosal injection materials, including PSC/Ge sol, PS sol, SH, and DW, using the dynamic viscoelastic test. During oscillation, the temperature was maintained at 23 °C for 30 seconds, then increased to 37 °C over a timespan of 30 seconds to trigger gelation, and subsequently maintained at 37 °C. Change in complex viscosity (η*) was registered throughout the test. The submucosal injection material NS exhibited too low a viscosity to allow measurement of η* with a rheometer; therefore, it was calculated using SEDNTERP (free software).


#

Pathological examination

We performed an in vitro examination to evaluate whether the collagen gel integrated with the submucosa. A 2-mL aliquot of PSC/Ge sol was injected into the submucosa of the porcine stomach in a live animal under general anesthesia. Fifteen minutes after injection, the swine was sacrificed, and we excised its stomach. We produced histologic sections from each block, stained them with hematoxylin-eosin (HE) and silver impregnation staining, and observed the submucosa under a microscope via high-magnification viewing.


#

Evaluation of cytotoxicity

Cell viability in PSC/Ge sol was tested to evaluate the cytotoxicity of the cell culture system using 24-well cell culture insert plates (IPs), in which the cells and sols were separated during cell culture.

To evaluate the cytotoxicity of cells that were shielded by the submucosa, a modified cell culture system was set up using collagen fibrillar gels to mimic the submucosa and employed for evaluation. A mixture of acid-solubilized collagen, concentrated PBS, and HEPES buffer, which contained NaOH, NaHCO3, and HEPES, was dispensed into the IPs to mimic the submucosa, followed by incubation at 37 °C for 30 minutes to form collagen gels. NIH-3T3 cell suspensions were spread onto the collagen gel-containing IPs (CIPs) to achieve a cell density of 1.1 × 105 cells/cm2. Simultaneously, PSC/Ge sol was individually poured into 24-well culture dishes (0.5 g/well) under conditions determined in prior studies and warmed in a water bath at 37 °C for 15 minutes or 10 minutes.

CIPs were plated in 24-well culture dishes containing PSC sol or PSC/Ge sol or in empty 24-well culture dishes as control cells; 0.2 mL or 1.4 mL of DMEM was added to the upper IPs or the bottom sols, respectively, in the well plates. The plates were then incubated at 37 °C for 24 hours.

The working solution containing CCK-8 in culture medium was added to both the upper insert plates and the bottom well plates. The absorbance of each well was measured at 450 nm using a microplate reader. The cell viability was calculated using the equation:

Cell viability (%) = (Ace/Ac) × 100

where Ace is the absorbance of the cells after the 24-hour exposure test, and Ac is the absorbance of control cells. Cell viability data are expressed as the mean ± SD.


#

Comparison of mean height and retention rate of submucosal elevation

We cut the upper third of resected porcine stomachs, which are reported to be similar to the human stomach, into approximately 5 × 5-cm square specimens and stretched them on a rubber board. Porcine stomachs were used within 2 hours of resection. One milliliter of each of the five solutions (PSC/Ge sol, PSC sol, SH, DW, and NS) was injected diagonally, as in practical endoscopic therapy, into the submucosa of the specimen using a 10.0-mL syringe and an endoscopic needle catheter (Fine Jet S2816, Top Co., Tokyo, Japan). The syringe was extruded using a mechanical syringe pump (KDS100, KD Scientific, United States) at 150 mL per hour. The needle catheter was heated to 30 °C to stimulate entry into the endoscopic channel using a water bath, and the porcine specimens were maintained at 37 °C (human body temperature) using a digital egg incubator (Rcom Max 20, Autoelex Co., Kyungsangnam-Do, Korea). This procedure was carried out in each group five times. We observed and subsequently recorded the height of the whole thickness of the stomach wall as mucosal elevation from the lateral direction using a measuring device immediately after and 15, 30, 45, and 60 minutes after injection. To equalize the observation settings, we photographed the subjects laterally at the same distance, and a ruler was set vertically beside the rubber plates. We compared mean heights of mucosal elevation immediately after injection as well as mean retention rates of mucosal elevation at each time after injection for the five solutions. Mean retention rate was calculated using the equation:

Retention rate (%) = (mucosal elevation of each timing/mucosal elevation after immediately injection) × 100


#

Statistical analysis

Statistical analysis was performed using statistical software (JMP, SAS Institute Inc, United States). Outcomes of the study of adequate condition settings for collagen sol for an endoscopic procedure and the comparison of mean height and retention rate of submucosal elevation were analyzed using the Tukey-Kramer test. A P value < 0.05 was considered to be statistically significant.


#
#

Results

Concentration of NaCl

[Fig. 1] shows Tg37 plotted against Tg30. Tg37 for 280 mMol NaCl in PB was faster than that for the other concentration. The result for Tg30 was greater than 10 minutes. Finally, we determined that the optimal concentration of NaCl in PB was 280 mMol (Tg37: 0.96 min, Tg30: 13.3 min).

Zoom Image
Fig. 1 Plots of Tg37 against Tg30.

#

Warming time and concentration of genipin

Tg37 decreased with increasing Ge concentration in all the PSC/Ge sols. The Tg37 of PSC sol in the absence of Ge was 3.5 minutes and decreased to 2.67 minutes as the Ge-0 concentration increased from 0 to 5.5 mM. The Tg37 of the sols containing 5.5 mM Ge decreased from 2.67 minutes to 0.79 minutes as the warming time of Ge increased from 0 to 48 hours. As a result, the Ge concentration-dependent decrease in Tg37 became steeper as the warming time of Ge increased ([Fig. 2a]). Tg37 monotonously increased as Tg30 increased and almost reached a plateau when Tg30 > 12 minutes ([Fig. 2b]). According to these results, we determined that the warming time of genipin was 24 hours, and we chose 2.8 mMol as the genipin concentration.

Zoom Image
Fig. 2 a Effects of genipin concentrations on Tg37 of the PSC/Ge sols containing various Ge samples. b Plots of Tg37 against Tg30 of the PSC/Ge sols containing various Ge samples at concentrations 0 – 5.5 mM.

#

Rheological evaluations of materials

[Fig. 3] shows the change in viscosity of the submucosal injection materials as they respond to increases in temperature from 23 °C to 37 °C. The η* of the PSC and PSC/Ge sols increased exponentially, responding to the increase in temperature, and the η* of PSC/Ge was higher than that of PSC at 10 minutes after the temperature reached 37 °C. In contrast, the η* of SH and DW did not show any change, mostly because they do not exhibit temperature responsiveness.

Zoom Image
Fig. 3 Viscosity change of various submucosal injection materials. Solid lines indicate complex viscosity (η*). Dotted line indicates set temperature of a rheometer. Normal saline (NS) was not tested.

#

Pathological examination

Although collagen gel was observed in the submucosa, evaluating whether it integrated with the submucosa via HE staining alone was difficult. However, we clearly observed collagen gel between the reticular fibers (surrounded by yellow circles in submucosa [Fig. 3b] and [Fig. 3d]) in the using silver impregnation staining. However, the gel did not extend vertically to the submucosa ( [Fig. 4a – d]).

Zoom Image
Fig. 4 The PSC gel in SM layer which was observed microscopically. a HE staining (× 20), b HE staining (× 100), c Sliver impregnation staining (× 20), d Sliver impregnation staining (× 100). PCS/Ge is present fully in b and d except reticular fiber; the spiral structure (surrounded yellow circle).

#

Evaluation of cytotoxicity

[Fig. 5] shows results of the cell viability tests using two types of cell culture systems. The cells cultured in the CIP-PSC system and the CIP-PSC/Ge system showed viabilities of 106 ± 6 % and 90.4 ± 5.9 %, respectively. The viability in the CIP-PSC/Ge system was significantly lower than that in the CIP-PSC system (P < 0.01).

Zoom Image
Fig. 5 Results of cell viability tests. Data are presented as mean ± SD (n = 5).

#

Comparison of mean height and retention rate of submucosal elevation

Mean heights of mucosal elevation of PSC/Ge sol (5.1 ± 0.74 mm), PSC sol (4.8 ± 0.84 mm), and SH (4.8 ± 0.76 mm) immediately after injection were significantly higher than that of NS (3.2 ± 0.84 mm) (P < 0.05) ([Fig. 6a]). Mean retention rate of mucosal elevation for PSC/Ge sol (100 ± 0 %) was shown to be significantly higher than those of NS (80.8 ± 5.6 %) and DW (79.3 ± 12.5 %) at 15 minutes after injection. At 30 minutes after injection, the value for PSC/Ge sol (100 ± 0 %) was significantly higher than those for NS (69.2 ± 5.6 %), DW (67.0 ± 12.9 %), and SH (71.2 ± 5.0 %). At 45 and 60 minutes after injection, PSC/Ge sol exhibited results similar to those seen 30 minutes after injection. PSC/Ge sol (100 ± 0 %) presented a significantly higher value than NS (61.7 ± 11.2 %), DW (67.0 ± 12.9 %), and SH (66.8 ± 7.1 %) at 45 minutes after injection. Finally, the value for PSC/Ge sol (100 ± 0.0%) was significantly higher than those for NS (61.7 ± 11.2%), DW (58.3 ± 11.8%) and SH (61.8 ± 8.6%) at 60 minutes after injection. Mean retention rates for mucosal elevation of PSC/Ge sol and PSC sol at 60 minutes after injection did not exhibit a significant difference (P = 0.08) ([Fig. 6b]). As shown in [Fig. 7], mucosal elevation of NS was completely extinguished at 60 minutes after injection. In contrast, we macroscopically observed that PSC/Ge sol formed a gel in the submucosa immediately after injection. Furthermore, PSC/Ge sol retained its formation and was fixed in the submucosa for at least 60 minutes.

Zoom Image
Fig. 6 a Comparison of SM elevation after immediately injection. b Transitive graph of retention rate of SM elevation until after 60 minutes after injection.
Zoom Image
Fig. 7 Sectional view of porcine stomachs. a just after injection of NS. b Sixty minutes after injection of NS. c Just after injection of the PSC/Ge sol. d Sixty minutes after injection of the PSC/Ge sol.

#
#

Discussion

In this study, we addressed PSC, PB, and genipin and determined the proper conditions for these substances according to previous reports [14] [15]. The optimal conditions maintain fluidity in an endoscope and an endoscopic catheter and result in rapid gelation in the submucosa. Our preliminary examinations showed that the channel temperature of an endoscope inserted into the porcine stomach via the esophagus was 30 °C; therefore, Tg30 indicates the minimum retention time of fluidity when the sol is introduced through the scope channel. In determining the concentration of NaCl, we emphasized that sufficient fluidity should be maintained in an endoscopic catheter, rather than focusing on the gelation time, and we adopted a concentration of 280 mMol because it is an integer multiple of the concentration of NS. Regarding determination of the warming time and concentration of genipin, we prioritized initiation of gelation within approximately 1 minutes at body temperature. Finally, we set the conditions of PSC/Ge sol as follows: PSC/2.8 mM Ge-24 sol in PB[50 – 280]. As shown in [Fig. 3], PSC/Ge sol initiated gelation immediately after reaching 37 °C, and the mechanical property increased linearly, sustainably, and rapidly over time. In addition, the mechanical property of PSC/Ge sol was greater than that of PSC sol throughout this examination because of the crosslinking effect of genipin.

We set the conditions of collagen, genipin, and PB to realize rapid gelation at 37 °C, similar to body temperature, and gelation was generally not observed at the temperature in the catheter lumen in this study. However, we had to prove that PSC/Ge sol integrated with the submucosa. Agents that only extend into the submucosa vertically are unsuitable as submucosal injection material for endoscopic procedures. If submucosal injection material extends into the submucosa vertically, it could lead to physical damage to surrounding tissue. Therefore, we conducted a pathological evaluation to confirm the integration of the collagen gel into the submucosa. We observed that PSC/Ge sol was present between the reticular fibers under silver impregnation staining, which indicated that PSC/Ge sol integrated with the SN and did not extend into the surrounding tissue vertically. Thus, PSC/Ge sol was suitable as a submucosal injection material.

Collagen has been used for clinical applications, and its safety in living tissue has been verified [16] [17] [18] [19]. In addition, genipin has long been used as a Kampo medicine, and it is reported to be safer than other crosslinking agents [14]. However, we performed an in vitro examination again to evaluate the cytotoxicity of genipin for use as a novel submucosal injection material. In this study, we modified the cell culture system using acid-solubilized collagen in CIPs that mimicked the submucosa to evaluate the cytotoxicity of cells present in the submucosa. This study revealed that the cytotoxicity of PSC/Ge sol was higher than that of PSC sol under both methods. However, we thought that this result was acceptable, being the result of an in vitro study, and should be comprehensively considered based on the results of an in vivo study for final clinical application.

Mean heights of the mucosal elevation of PSC/Ge sol and PSC sol immediately after injection were significantly higher than that of NS; mean retention rates of the mucosal elevation of PSC/Ge sol and PSC sol at 60 minutes after injection were significantly higher than those of SH, DW and NS. These results indicate that PSC/Ge sol and PSC sol represent good submucosal injection materials. Although there was no significant difference between PSC/Ge sol and PSC sol when retention rates of mucosal elevation were compared, PSC/Ge sol exhibited a higher storage modulus than that of PSC sol in rheometer testing. Genipin increased the mechanical properties of collagen by crosslinking collagen fibers, which could lead to a 100 % retention rate of PSC/Ge sol at 60 min. Based on these results, we concluded that PSC/Ge sol is better than PSC sol as a submucosal injection material.

In addition, PSC/Ge sol costs approximately 11 USD (calculated at 100 yen per dollar) for 20 mL, as calculated from the material cost. In contrast, SH costs approximately 42.5 USD for 20 mL, as calculated from the material cost in Japan. Thus, PSC/Ge is approximately one-quarter the price of SH in terms of material cost. Furthermore, it may be possible to perform endoscopic intervention using less PSC/Ge sol than SH because it remains in the submucosa for a long period according to study 4. Therefore, it could have a good effect on the medical economy.

In this study, we investigated the physical properties of each material quantitatively with a rheometer. Although there have been many reports in which the retention rate of the mucosal elevation has been configured as a barometer of physical properties [3] [4] [8], no studies have evaluated physical properties with a rheometer. Although most studies evaluate safety through in vivo experiments, no reports exist of evaluation of cytotoxicity of submucosal injection material through in vitro experiments. We adopted precise, objective measurement methods in this study. Therefore, the results of our study are very reliable compared to past reports.

There are some limitations to this study. First, this was an in vitro study. We investigated only the basal properties of PSC/Ge sol and PSC sol. An in vivo study needs to be conducted to validate the safety and usability of these products using a live porcine model for clinical application. Second, we did not evaluate the retention rate of the mucosal elevation after 60 minutes post-injection. Endoscopic resection procedure times are currently seldom greater than 1 hour, although progress in endoscopic techniques and devices has enabled more difficult and challenging cases to be addressed. Therefore, a long-term dynamic analysis of PSC/Ge sol should be performed over 1 hour.


#

Conclusion

In conclusion, we suggest that the basal properties of collagen and genipin make them suitable as a submucosal injection material for endoscopic resection. PSC/Ge sol integrated with the submucosa macroscopically and showed relatively low cytotoxicity. Moreover, PSC/Ge sol exhibited a good retention rate of the mucosal elevation compared to existing submucosal injection material by crosslinking with genipin. Therefore, PSC/Ge sol is considered to be a good submucosal injection material. In vivo studies to evaluate the safety and usability of PSC/Ge sol will be necessary in the near future.


#
#

Competing interests

None

  • References

  • 1 Soetikno RM, Gotoda T, Nakanishi Y. et al. Endoscopic mucosal resection. Gastrointest Endosc 2003; 57: 567-579
  • 2 Antillon MR, Bartalos CR, Miller ML. et al. En bloc endoscopic submucosal dissection of a 14-cm laterally spreading adenoma of the rectum with involvement to the anal canal: expanding the frontiers of endoscopic surgery (with video). Gastrointest Endosc 2008; 67: 332-337
  • 3 Liu W, Zhao M, Liu W. et al. A feasibility study of a thermally sensitive elastin-like polypeptide for submucosal injection application in endoscopic resection in 3 animal models. Gastrointest Endosc 2015; 82: 944-952
  • 4 Fujishiro M, Yahagi N, Kashimura K. et al. Comparison of various submucosal injection solutions for maintaining mucosal elevation during endoscopic mucosal resection. Endoscopy 2004; 36: 579-583
  • 5 Hikichi T, Yamasaki M, Watanabe K. et al. Gastric endoscopic submucosal dissection using sodium carboxymethylcellulose as a new injection substance. Fukushima J Med Sci 2016; 62: 43-50
  • 6 Pioche M, Lepilliez V, Deprez P. et al. High pressure jet injection of viscous solutions for endoscopic submucosal dissection (ESD): first clinical experience. Endosc Int Open 2015; 3: E368-372
  • 7 Wen W, Shi C, Shi Y. et al. A pilot animal and clinical study of autologous blood solution compared with normal saline for use as an endoscopic submucosal cushion. Exper Therap Med 2012; 4: 419-424
  • 8 Akagi T, Yasuda K, Tajima M. et al. Sodium alginate as an ideal submucosal injection material for endoscopic submucosal resection: preliminary experimental and clinical study. Gastrointest Endosc 2011; 74: 1026-1032
  • 9 Uraoka T, Kawahara Y, Ohara N. et al. Carbon dioxide submucosal injection cushion: an innovative technique in endoscopic submucosal dissection. Digest Endosc 2011; 23: 5-9
  • 10 Liu W, Wang M, Zhao L. et al. Thermo-sensitive isopentane aerification for mucosal lift during endoscopic resection in animal models (with video). Gastrointest Endosc 2017; 86: 1168-1175 e1163
  • 11 Sundararaghavan HG, Monteiro GA, Lapin NA. et al. Genipin-induced changes in collagen gels: correlation of mechanical properties to fluorescence. J Biomed Mater Res Part A 2008; 87: 308-320
  • 12 Yunoki S, Ohyabu Y, Hatayama H. Temperature-responsive gelation of type I collagen solutions involving fibril formation and genipin crosslinking as a potential injectable hydrogel. Int J Biomater 2013; 2013: 620765
  • 13 Narita T, Yunoki S, Ohyabu Y. et al. In situ gelation properties of a collagen-genipin sol with a potential for the treatment of gastrointestinal ulcers. Med Devices (Auckl) 2016; 9: 429-439
  • 14 Sung HW, Huang RN, Huang LL. et al. Feasibility study of a natural crosslinking reagent for biological tissue fixation. J Biomed Mat Res 1998; 42: 560-567
  • 15 Yunoki S, Hatayama H, Ebisawa M. et al. A novel fabrication method to create a thick collagen bundle composed of uniaxially aligned fibrils: an essential technology for the development of artificial tendon/ligament matrices. J Biomed Mat Res Part A 2015; 103: 3054-3065
  • 16 Ruszczak Z, Schwartz RA. Collagen uses in dermatology – an update. Dermatology (Basel, Switzerland) 1999; 199: 285-289
  • 17 Charriere G, Bejot M, Schnitzler L. et al. Reactions to a bovine collagen implant. Clinical immunologic study in 705 patients. J Am Acad Dermatol 1989; 21: 1203-1208
  • 18 Macaya D, Spector M. Injectable collagen-genipin gel for the treatment of spinal cord injury: in vitro studies. Advanced Functional Materials 2011; 21: 4788-4797
  • 19 Yen Chang C-CT, Huang-Chien Liang, Hsing-Wen Sung. In vivo evaluation of cellular an acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 2002; 23: 2447-2457

Corresponding author

Toshio Uraoka, MD, PhD
Department of Gastroenterology and Hepatology
Gunma University School of Medicine
3-39-22, Showa-machi, Maebashi-shi
Gunma, 371-8511
Japan   
Fax: +81-27-220-7798   

  • References

  • 1 Soetikno RM, Gotoda T, Nakanishi Y. et al. Endoscopic mucosal resection. Gastrointest Endosc 2003; 57: 567-579
  • 2 Antillon MR, Bartalos CR, Miller ML. et al. En bloc endoscopic submucosal dissection of a 14-cm laterally spreading adenoma of the rectum with involvement to the anal canal: expanding the frontiers of endoscopic surgery (with video). Gastrointest Endosc 2008; 67: 332-337
  • 3 Liu W, Zhao M, Liu W. et al. A feasibility study of a thermally sensitive elastin-like polypeptide for submucosal injection application in endoscopic resection in 3 animal models. Gastrointest Endosc 2015; 82: 944-952
  • 4 Fujishiro M, Yahagi N, Kashimura K. et al. Comparison of various submucosal injection solutions for maintaining mucosal elevation during endoscopic mucosal resection. Endoscopy 2004; 36: 579-583
  • 5 Hikichi T, Yamasaki M, Watanabe K. et al. Gastric endoscopic submucosal dissection using sodium carboxymethylcellulose as a new injection substance. Fukushima J Med Sci 2016; 62: 43-50
  • 6 Pioche M, Lepilliez V, Deprez P. et al. High pressure jet injection of viscous solutions for endoscopic submucosal dissection (ESD): first clinical experience. Endosc Int Open 2015; 3: E368-372
  • 7 Wen W, Shi C, Shi Y. et al. A pilot animal and clinical study of autologous blood solution compared with normal saline for use as an endoscopic submucosal cushion. Exper Therap Med 2012; 4: 419-424
  • 8 Akagi T, Yasuda K, Tajima M. et al. Sodium alginate as an ideal submucosal injection material for endoscopic submucosal resection: preliminary experimental and clinical study. Gastrointest Endosc 2011; 74: 1026-1032
  • 9 Uraoka T, Kawahara Y, Ohara N. et al. Carbon dioxide submucosal injection cushion: an innovative technique in endoscopic submucosal dissection. Digest Endosc 2011; 23: 5-9
  • 10 Liu W, Wang M, Zhao L. et al. Thermo-sensitive isopentane aerification for mucosal lift during endoscopic resection in animal models (with video). Gastrointest Endosc 2017; 86: 1168-1175 e1163
  • 11 Sundararaghavan HG, Monteiro GA, Lapin NA. et al. Genipin-induced changes in collagen gels: correlation of mechanical properties to fluorescence. J Biomed Mater Res Part A 2008; 87: 308-320
  • 12 Yunoki S, Ohyabu Y, Hatayama H. Temperature-responsive gelation of type I collagen solutions involving fibril formation and genipin crosslinking as a potential injectable hydrogel. Int J Biomater 2013; 2013: 620765
  • 13 Narita T, Yunoki S, Ohyabu Y. et al. In situ gelation properties of a collagen-genipin sol with a potential for the treatment of gastrointestinal ulcers. Med Devices (Auckl) 2016; 9: 429-439
  • 14 Sung HW, Huang RN, Huang LL. et al. Feasibility study of a natural crosslinking reagent for biological tissue fixation. J Biomed Mat Res 1998; 42: 560-567
  • 15 Yunoki S, Hatayama H, Ebisawa M. et al. A novel fabrication method to create a thick collagen bundle composed of uniaxially aligned fibrils: an essential technology for the development of artificial tendon/ligament matrices. J Biomed Mat Res Part A 2015; 103: 3054-3065
  • 16 Ruszczak Z, Schwartz RA. Collagen uses in dermatology – an update. Dermatology (Basel, Switzerland) 1999; 199: 285-289
  • 17 Charriere G, Bejot M, Schnitzler L. et al. Reactions to a bovine collagen implant. Clinical immunologic study in 705 patients. J Am Acad Dermatol 1989; 21: 1203-1208
  • 18 Macaya D, Spector M. Injectable collagen-genipin gel for the treatment of spinal cord injury: in vitro studies. Advanced Functional Materials 2011; 21: 4788-4797
  • 19 Yen Chang C-CT, Huang-Chien Liang, Hsing-Wen Sung. In vivo evaluation of cellular an acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 2002; 23: 2447-2457

Zoom Image
Fig. 1 Plots of Tg37 against Tg30.
Zoom Image
Fig. 2 a Effects of genipin concentrations on Tg37 of the PSC/Ge sols containing various Ge samples. b Plots of Tg37 against Tg30 of the PSC/Ge sols containing various Ge samples at concentrations 0 – 5.5 mM.
Zoom Image
Fig. 3 Viscosity change of various submucosal injection materials. Solid lines indicate complex viscosity (η*). Dotted line indicates set temperature of a rheometer. Normal saline (NS) was not tested.
Zoom Image
Fig. 4 The PSC gel in SM layer which was observed microscopically. a HE staining (× 20), b HE staining (× 100), c Sliver impregnation staining (× 20), d Sliver impregnation staining (× 100). PCS/Ge is present fully in b and d except reticular fiber; the spiral structure (surrounded yellow circle).
Zoom Image
Fig. 5 Results of cell viability tests. Data are presented as mean ± SD (n = 5).
Zoom Image
Fig. 6 a Comparison of SM elevation after immediately injection. b Transitive graph of retention rate of SM elevation until after 60 minutes after injection.
Zoom Image
Fig. 7 Sectional view of porcine stomachs. a just after injection of NS. b Sixty minutes after injection of NS. c Just after injection of the PSC/Ge sol. d Sixty minutes after injection of the PSC/Ge sol.